NYLIM
AVNS

New York Life Investment Management’s Avanos Medical AVNS Stock Holding History

New York Life Investment Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.83M Buy
+73,455
New +$1.72M 0.01% 566
2024
Q2 		– Sell
-18,202
Closed -$362K – 903
2024
Q1 		$362K Buy
18,202
+6,500
+56% +$126K ﹤0.01% 1156
2023
Q4 		$262K Sell
11,702
-270
-2% -$5.57K ﹤0.01% 1259
2023
Q3 		$242K Sell
11,972
-1,899
-14% -$43K ﹤0.01% 1244
2023
Q2 		$355K Sell
13,871
-2,822
-17% -$74.3K ﹤0.01% 1158
2023
Q1 		$496K Sell
16,693
-238
-1% -$6.91K 0.01% 693
2022
Q4 		$458K Buy
16,931
+1,907
+13% +$46.6K 0.01% 981
2022
Q3 		$327K Buy
15,024
+1,103
+8% +$28.8K ﹤0.01% 1064
2022
Q2 		$381K Buy
+13,921
New +$400K ﹤0.01% 1022
2015
Q4 		– Sell
-9,080
Closed -$258K – 66
2015
Q3 		$258K Buy
9,080
+438
+5% +$15.3K 0.02% 185
2015
Q2 		$350K Buy
+8,642
New +$388K 0.04% 138

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SRC
Samson Rock Capital London, United Kingdom $45.6M AUM 86.17% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return

New York Life Investment Management's AVNS Position: Q2 2026 in Review

New York Life Investment Management opened a new position in Avanos Medical (AVNS) in Q2 2026: 73,455 shares worth $1.83M. The stake represents 0.01% of the portfolio and ranks #566 among its holdings. This is a return to the name: New York Life Investment Management previously reported a position in AVNS as recently as Q1 2024.

New York Life Investment Management first reported a position in AVNS in Q2 2015 and has held it in 11 quarters since. 166 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • New York Life Investment Management held 73,455 shares of Avanos Medical worth $1.83M as of Q2 2026.
  • Avanos Medical was a new New York Life Investment Management position in Q2 2026.
  • Avanos Medical made up 0.01% of New York Life Investment Management's portfolio in Q2 2026, its #566 holding.
  • New York Life Investment Management first reported a position in Avanos Medical in Q2 2015 and has held it in 11 quarters since.
  • 166 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.